{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:56:08Z","timestamp":1793321768435,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"DOI":"10.1007\/s11914-026-00971-4","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:48:13Z","timestamp":1778892493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Testosterone and Bone Health in Men"],"prefix":"10.1007","volume":"24","author":[{"given":"Hussein","family":"Kafel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehzad","family":"Basaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,16]]},"reference":[{"issue":"9924","key":"971_CR1","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/S0140-6736(13)61126-5","volume":"383","author":"S Basaria","year":"2014","unstructured":"Basaria S. Male hypogonadism. Lancet. 2014;383(9924):1250\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(13)61126-5.","journal-title":"Lancet"},{"issue":"5","key":"971_CR2","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1210\/jc.2018-00229","volume":"103","author":"S Bhasin","year":"2018","unstructured":"Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715\u201344. https:\/\/doi.org\/10.1210\/jc.2018-00229.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"971_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.4158\/EP.8.6.439","volume":"8","author":"SM Petak","year":"2002","unstructured":"Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez-Rigau LJ, American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update. Endocr Pract. 2002;8(6):440\u201356.","journal-title":"Endocr Pract"},{"issue":"7","key":"971_CR4","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrendo.2013.73","volume":"9","author":"M Spitzer","year":"2013","unstructured":"Spitzer M, Huang G, Basaria S, Travison TG, Bhasin S. Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol. 2013;9(7):414\u201324. https:\/\/doi.org\/10.1038\/nrendo.2013.73.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"971_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2164\/jandrol.108.006486","volume":"30","author":"C Wang","year":"2009","unstructured":"Wang C, Nieschlag E, Swerdloff R, et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl. 2009;30(1):1\u20139. https:\/\/doi.org\/10.2164\/jandrol.108.006486.","journal-title":"J Androl"},{"issue":"7","key":"971_CR6","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1210\/jc.2007-1972","volume":"93","author":"FC Wu","year":"2008","unstructured":"Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93(7):2737\u201345. https:\/\/doi.org\/10.1210\/jc.2007-1972.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"971_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","volume":"87","author":"HA Feldman","year":"2002","unstructured":"Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002;87(2):589\u201398. https:\/\/doi.org\/10.1210\/jcem.87.2.8201.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"971_CR8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/jcem.86.2.7219","volume":"86","author":"SM Harman","year":"2001","unstructured":"Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86(2):724\u201331. https:\/\/doi.org\/10.1210\/jcem.86.2.7219.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"971_CR9","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/s0026-0495(97)90057-3","volume":"46","author":"JE Morley","year":"1997","unstructured":"Morley JE, Kaiser FE, Perry HM 3rd, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997;46(4):410\u20133. https:\/\/doi.org\/10.1016\/s0026-0495(97)90057-3.","journal-title":"Metabolism"},{"issue":"8","key":"971_CR10","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/oxfordjournals.aje.a009326","volume":"146","author":"JM Zmuda","year":"1997","unstructured":"Zmuda JM, Cauley JA, Kriska A, Glynn NW, Gutai JP, Kuller LH. Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants. Am J Epidemiol. 1997;146(8):609\u201317. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a009326.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"971_CR11","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1210\/jc.2016-2935","volume":"102","author":"TG Travison","year":"2017","unstructured":"Travison TG, Vesper HW, Orwoll E, et al. Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102(4):1161\u201373. https:\/\/doi.org\/10.1210\/jc.2016-2935.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"971_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030530","volume":"10","author":"K Shigehara","year":"2021","unstructured":"Shigehara K, Izumi K, Kadono Y, Mizokami A. Testosterone and bone health in men: a narrative review. J Clin Med. 2021;10(3):530. https:\/\/doi.org\/10.3390\/jcm10030530. (Published 2021 Feb 2).","journal-title":"J Clin Med"},{"key":"971_CR13","unstructured":"Nassar GN, Leslie SW. Physiology, Testosterone. In:\u00a0StatPearls. Treasure Island (FL): StatPearls Publishing; 2023."},{"key":"971_CR14","unstructured":"Bhasin S, Valderr\u00e1bano RJ, Gagliano-Juc\u00e1 T et al. Age-Related Changes in the Male Reproductive System. In: Feingold KR, Ahmed SF, Anawalt B, eds. Endotext. South Dartmouth (MA): MDText.com, Inc.; 2022."},{"key":"971_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/andr.70013","author":"H Kafel","year":"2025","unstructured":"Kafel H, Braga-Basaria M, Basaria S. Opioid-induced androgen deficiency in men: prevalence, pathophysiology, and efficacy of testosterone therapy. Andrology. 2025. https:\/\/doi.org\/10.1111\/andr.70013.","journal-title":"Andrology"},{"issue":"6","key":"971_CR16","doi-asserted-by":"publisher","first-page":"861","DOI":"10.7326\/AITC202401160","volume":"27","author":"F Albright","year":"1947","unstructured":"Albright F. Osteoporosis. Ann Intern Med. 1947;27(6):861\u201382. https:\/\/doi.org\/10.7326\/AITC202401160.","journal-title":"Ann Intern Med"},{"issue":"1","key":"971_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031211","volume":"8","author":"S Khosla","year":"2018","unstructured":"Khosla S, Monroe DG. Regulation of bone metabolism by sex steroids. Cold Spring Harb Perspect Med. 2018;8(1):a031211. https:\/\/doi.org\/10.1101\/cshperspect.a031211. (Published 2018 Jan 2).","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"3","key":"971_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.steroids.2008.10.003","volume":"74","author":"BL Clarke","year":"2009","unstructured":"Clarke BL, Khosla S. Androgens and bone. Steroids. 2009;74(3):296\u2013305. https:\/\/doi.org\/10.1016\/j.steroids.2008.10.003.","journal-title":"Steroids"},{"issue":"3","key":"971_CR19","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1172\/JCI85006","volume":"126","author":"TJ Weber","year":"2016","unstructured":"Weber TJ. Battle of the sex steroids in the male skeleton: and the winner is.... J Clin Invest. 2016;126(3):829\u201332. https:\/\/doi.org\/10.1172\/JCI85006.","journal-title":"J Clin Invest"},{"issue":"2","key":"971_CR20","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1152\/advan.90111.2008","volume":"32","author":"M Brown","year":"2008","unstructured":"Brown M. Skeletal muscle and bone: effect of sex steroids and aging. Adv Physiol Educ. 2008;32(2):120\u20136. https:\/\/doi.org\/10.1152\/advan.90111.2008.","journal-title":"Adv Physiol Educ"},{"issue":"3","key":"971_CR21","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","volume":"23","author":"BL Riggs","year":"2002","unstructured":"Riggs BL, Khosla S, Melton LJ 3rd. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev. 2002;23(3):279\u2013302. https:\/\/doi.org\/10.1210\/edrv.23.3.0465.","journal-title":"Endocr Rev"},{"issue":"3","key":"971_CR22","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.tips.2025.01.007","volume":"46","author":"H Kalyanaraman","year":"2025","unstructured":"Kalyanaraman H, Pal China S, Casteel DE, Pilz RB. Crosstalk between androgen receptor and protein kinase G signaling in bone: implications for osteoporosis therapy. Trends Pharmacol Sci. 2025;46(3):279\u201394. https:\/\/doi.org\/10.1016\/j.tips.2025.01.007.","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"971_CR23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.82917","volume":"17","author":"JG Rojas-Zambrano","year":"2025","unstructured":"Rojas-Zambrano JG, Rojas-Zambrano A, Rojas-Zambrano AF. Impact of testosterone on male health: a systematic review. Cureus. 2025;17(4):e82917. https:\/\/doi.org\/10.7759\/cureus.82917. (Published 2025 Apr 24).","journal-title":"Cureus"},{"issue":"1","key":"971_CR24","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1210\/jc.2002-021036","volume":"88","author":"BZ Leder","year":"2003","unstructured":"Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS. Differential effects of androgens and estrogens on bone turnover in normal men. J Clin Endocrinol Metab. 2003;88(1):204\u201310. https:\/\/doi.org\/10.1210\/jc.2002-021036.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"971_CR25","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1359\/JBMR.050803","volume":"20","author":"H Michael","year":"2005","unstructured":"Michael H, H\u00e4rk\u00f6nen PL, V\u00e4\u00e4n\u00e4nen HK, Hentunen TA. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res. 2005;20(12):2224\u201332. https:\/\/doi.org\/10.1359\/JBMR.050803.","journal-title":"J Bone Miner Res"},{"issue":"9","key":"971_CR26","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1210\/jcem.82.9.4200","volume":"82","author":"A Tomkinson","year":"1997","unstructured":"Tomkinson A, Reeve J, Shaw RW, Noble BS. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab. 1997;82(9):3128\u201335. https:\/\/doi.org\/10.1210\/jcem.82.9.4200.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"971_CR27","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1210\/jc.2003-030054","volume":"88","author":"S Khosla","year":"2003","unstructured":"Khosla S, Riggs BL. Androgens, estrogens, and bone turnover in men. J Clin Endocrinol Metab. 2003;88(5):2352\u20133. https:\/\/doi.org\/10.1210\/jc.2003-030054.","journal-title":"J Clin Endocrinol Metab"},{"key":"971_CR28","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/240328","volume":"2011","author":"M Sinnesael","year":"2011","unstructured":"Sinnesael M, Boonen S, Claessens F, Gielen E, Vanderschueren D. Testosterone and the male skeleton: a dual mode of action. J Osteoporos. 2011;2011:240328. https:\/\/doi.org\/10.4061\/2011\/240328.","journal-title":"J Osteoporos"},{"issue":"7","key":"971_CR29","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1210\/clinem\/dgae703","volume":"110","author":"L Grahnemo","year":"2025","unstructured":"Grahnemo L, Marriott RJ, Murray K, et al. Associations of serum testosterone and SHBG with incident fractures in middle-aged to older men. J Clin Endocrinol Metab. 2025;110(7):1964\u201373. https:\/\/doi.org\/10.1210\/clinem\/dgae703.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"971_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-024-01316-5","volume":"22","author":"H Cheng","year":"2024","unstructured":"Cheng H, Zhang X, Li Y, et al. Age-related testosterone decline: mechanisms and intervention strategies. Reprod Biol Endocrinol. 2024;22(1):144. https:\/\/doi.org\/10.1186\/s12958-024-01316-5. (Published 2024 Nov 14).","journal-title":"Reprod Biol Endocrinol"},{"issue":"9","key":"971_CR31","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1210\/jc.2009-0206","volume":"94","author":"ES LeBlanc","year":"2009","unstructured":"LeBlanc ES, Nielson CM, Marshall LM, et al. The effects of serum testosterone, estradiol, and Sex Hormone Binding Globulin levels on fracture risk in older men. J Clin Endocrinol Metab. 2009;94(9):3337\u201346. https:\/\/doi.org\/10.1210\/jc.2009-0206.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"971_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/s0169-6009(08)80022-0","volume":"20","author":"S Murphy","year":"1993","unstructured":"Murphy S, Khaw KT, Cassidy A, Compston JE. Sex hormones and bone mineral density in elderly men. Bone Miner. 1993;20(2):133\u201340. https:\/\/doi.org\/10.1016\/s0169-6009(08)80022-0.","journal-title":"Bone Miner"},{"issue":"11","key":"971_CR33","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1359\/jbmr.1997.12.11.1833","volume":"12","author":"GA Greendale","year":"1997","unstructured":"Greendale GA, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res. 1997;12(11):1833\u201343. https:\/\/doi.org\/10.1359\/jbmr.1997.12.11.1833.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"971_CR34","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/archinternmed.2007.2","volume":"168","author":"C Meier","year":"2008","unstructured":"Meier C, Nguyen TV, Handelsman DJ, et al. Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med. 2008;168(1):47\u201354. https:\/\/doi.org\/10.1001\/archinternmed.2007.2.","journal-title":"Arch Intern Med"},{"issue":"10","key":"971_CR35","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1359\/jbmr.080518","volume":"23","author":"D Mellstr\u00f6m","year":"2008","unstructured":"Mellstr\u00f6m D, Vandenput L, Mallmin H, et al. Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. J Bone Miner Res. 2008;23(10):1552\u201360. https:\/\/doi.org\/10.1359\/jbmr.080518.","journal-title":"J Bone Miner Res"},{"key":"971_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.bone.2016.01.009","volume":"84","author":"PM Cawthon","year":"2016","unstructured":"Cawthon PM, Schousboe JT, Harrison SL, et al. Sex hormones, sex hormone binding globulin, and vertebral fractures in older men. Bone. 2016;84:271\u20138. https:\/\/doi.org\/10.1016\/j.bone.2016.01.009.","journal-title":"Bone"},{"issue":"10","key":"971_CR37","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1210\/jc.2006-0173","volume":"91","author":"HA Fink","year":"2006","unstructured":"Fink HA, Ewing SK, Ensrud KE, et al. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab. 2006;91(10):3908\u201315. https:\/\/doi.org\/10.1210\/jc.2006-0173.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"971_CR38","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1210\/jc.2009-2635","volume":"95","author":"JA Cauley","year":"2010","unstructured":"Cauley JA, Ewing SK, Taylor BC, et al. Sex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density--the osteoporotic fractures in men study. J Clin Endocrinol Metab. 2010;95(9):4314\u201323. https:\/\/doi.org\/10.1210\/jc.2009-2635.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"971_CR39","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1002\/jbmr.2901","volume":"31","author":"GN Woods","year":"2016","unstructured":"Woods GN, Huang MH, Cawthon PM, et al. SHBG, Sex Steroids, and Kyphosis in Older Men: The MrOS Study. J Bone Miner Res. 2016;31(12):2123\u20138. https:\/\/doi.org\/10.1002\/jbmr.2901.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"971_CR40","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1359\/jbmr.060110","volume":"21","author":"D Mellstr\u00f6m","year":"2006","unstructured":"Mellstr\u00f6m D, Johnell O, Ljunggren O, et al. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J Bone Miner Res. 2006;21(4):529\u201335. https:\/\/doi.org\/10.1359\/jbmr.060110.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"971_CR41","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/ard.59.10.765","volume":"59","author":"JM Kaufman","year":"2000","unstructured":"Kaufman JM, Johnell O, Abadie E, et al. Background for studies on the treatment of male osteoporosis: state of the art. Ann Rheum Dis. 2000;59(10):765\u201372. https:\/\/doi.org\/10.1136\/ard.59.10.765.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"971_CR42","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1210\/jcem-69-3-523","volume":"69","author":"JJ St\u0115p\u00e1n","year":"1989","unstructured":"St\u0115p\u00e1n JJ, Lachman M, Zv\u0115rina J, Pacovsk\u00fd V, Baylink DJ. Castrated men exhibit bone loss: effect of calcitonin treatment on biochemical indices of bone remodeling. J Clin Endocrinol Metab. 1989;69(3):523\u20137. https:\/\/doi.org\/10.1210\/jcem-69-3-523.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"971_CR43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1210\/jcem.76.2.7679397","volume":"76","author":"D Goldray","year":"1993","unstructured":"Goldray D, Weisman Y, Jaccard N, Merdler C, Chen J, Matzkin H. Decreased bone density in elderly men treated with the gonadotropin-releasing hormone agonist decapeptyl (D-Trp6-GnRH). J Clin Endocrinol Metab. 1993;76(2):288\u201390. https:\/\/doi.org\/10.1210\/jcem.76.2.7679397.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"971_CR44","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJMoa041943","volume":"352","author":"VB Shahinian","year":"2005","unstructured":"Shahinian VB, Kuo YF, Freeman JL, Goodwin JS. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med. 2005;352(2):154\u201364. https:\/\/doi.org\/10.1056\/NEJMoa041943.","journal-title":"N Engl J Med"},{"issue":"6","key":"971_CR45","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1210\/jcem.86.6.7558","volume":"86","author":"SA Stoch","year":"2001","unstructured":"Stoch SA, Parker RA, Chen L, et al. Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab. 2001;86(6):2787\u201391. https:\/\/doi.org\/10.1210\/jcem.86.6.7558.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"971_CR46","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1210\/jcem.87.8.8782","volume":"87","author":"D Mittan","year":"2002","unstructured":"Mittan D, Lee S, Miller E, Perez RC, Basler JW, Bruder JM. Bone loss following hypogonadism in men with prostate cancer treated with GnRH analogs. J Clin Endocrinol Metab. 2002;87(8):3656\u201361. https:\/\/doi.org\/10.1210\/jcem.87.8.8782.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"971_CR47","doi-asserted-by":"publisher","first-page":"6410","DOI":"10.1210\/jc.2005-0183","volume":"90","author":"SL Greenspan","year":"2005","unstructured":"Greenspan SL, Coates P, Sereika SM, Nelson JB, Trump DL, Resnick NM. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab. 2005;90(12):6410\u20137. https:\/\/doi.org\/10.1210\/jc.2005-0183.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"971_CR48","doi-asserted-by":"publisher","first-page":"e2121","DOI":"10.1210\/clinem\/dgaf191","volume":"110","author":"M Tenuta","year":"2025","unstructured":"Tenuta M, Hasenmajer V, Gianfrilli D, Isidori AM. Testosterone and male bone health: a puzzle of interactions. J Clin Endocrinol Metab. 2025;110(7):e2121\u201335. https:\/\/doi.org\/10.1210\/clinem\/dgaf191.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"971_CR49","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s11154-022-09751-8","volume":"23","author":"T Gagliano-Juc\u00e1","year":"2022","unstructured":"Gagliano-Juc\u00e1 T, Alvarez M, Basaria S. The medicalization of testosterone: reinventing the elixir of life. Rev Endocr Metab Disord. 2022;23(6):1275\u201384. https:\/\/doi.org\/10.1007\/s11154-022-09751-8.","journal-title":"Rev Endocr Metab Disord"},{"issue":"3","key":"971_CR50","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa2308836","volume":"390","author":"PJ Snyder","year":"2024","unstructured":"Snyder PJ, Bauer DC, Ellenberg SS, et al. Testosterone treatment and fractures in men with hypogonadism. N Engl J Med. 2024;390(3):203\u201311. https:\/\/doi.org\/10.1056\/NEJMoa2308836.","journal-title":"N Engl J Med"},{"issue":"3","key":"971_CR51","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1210\/er.2017-00234","volume":"39","author":"PJ Snyder","year":"2018","unstructured":"Snyder PJ, Bhasin S, Cunningham GR, et al. Lessons from the testosterone trials. Endocr Rev. 2018;39(3):369\u201386. https:\/\/doi.org\/10.1210\/er.2017-00234.","journal-title":"Endocr Rev"},{"issue":"12","key":"971_CR52","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1210\/jcem.81.12.8954042","volume":"81","author":"L Katznelson","year":"1996","unstructured":"Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab. 1996;81(12):4358\u201365. https:\/\/doi.org\/10.1210\/jcem.81.12.8954042.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"971_CR53","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1210\/jcem.82.8.4163","volume":"82","author":"HM Behre","year":"1997","unstructured":"Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 1997;82(8):2386\u201390. https:\/\/doi.org\/10.1210\/jcem.82.8.4163.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"971_CR54","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1530\/eje.0.1380051","volume":"138","author":"E Leifke","year":"1998","unstructured":"Leifke E, K\u00f6rner HC, Link TM, Behre HM, Peters PE, Nieschlag E. Effects of testosterone replacement therapy on cortical and trabecular bone mineral density, vertebral body area and paraspinal muscle area in hypogonadal men. Eur J Endocrinol. 1998;138(1):51\u20138. https:\/\/doi.org\/10.1530\/eje.0.1380051.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"971_CR55","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1210\/jcem.82.2.3758","volume":"82","author":"CY Guo","year":"1997","unstructured":"Guo CY, Jones TH, Eastell R. Treatment of isolated hypogonadotropic hypogonadism effect on bone mineral density and bone turnover. J Clin Endocrinol Metab. 1997;82(2):658\u201365. https:\/\/doi.org\/10.1210\/jcem.82.2.3758.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"971_CR56","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1530\/eje.1.01920","volume":"152","author":"A Aminorroaya","year":"2005","unstructured":"Aminorroaya A, Kelleher S, Conway AJ, Ly LP, Handelsman DJ. Adequacy of androgen replacement influences bone density response to testosterone in androgen-deficient men. Eur J Endocrinol. 2005;152(6):881\u20136. https:\/\/doi.org\/10.1530\/eje.1.01920.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"971_CR57","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1046\/j.1365-2265.2001.01271.x","volume":"54","author":"C Wang","year":"2001","unstructured":"Wang C, Swerdloff RS, Iranmanesh A, et al. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf). 2001;54(6):739\u201350. https:\/\/doi.org\/10.1046\/j.1365-2265.2001.01271.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"971_CR58","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1210\/jcem-69-4-776","volume":"69","author":"JS Finkelstein","year":"1989","unstructured":"Finkelstein JS, Klibanski A, Neer RM, et al. Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1989;69(4):776\u201383. https:\/\/doi.org\/10.1210\/jcem-69-4-776.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"971_CR59","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1210\/clinem\/dgaa318","volume":"105","author":"JS Finkelstein","year":"2020","unstructured":"Finkelstein JS, Lee H, Burnett-Bowie SM, et al. Dose-Response Relationships Between Gonadal Steroids and Bone, Body Composition, and Sexual Function in Aging Men. J Clin Endocrinol Metab. 2020;105(8):2779\u201388. https:\/\/doi.org\/10.1210\/clinem\/dgaa318.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"971_CR60","doi-asserted-by":"publisher","first-page":"354","DOI":"10.7326\/0003-4819-106-3","volume":"106","author":"JS Finkelstein","year":"1987","unstructured":"Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF Jr. Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med. 1987;106(3):354\u201361. https:\/\/doi.org\/10.7326\/0003-4819-106-3.","journal-title":"Ann Intern Med"},{"issue":"3","key":"971_CR61","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1172\/JCI84137","volume":"126","author":"JS Finkelstein","year":"2016","unstructured":"Finkelstein JS, Lee H, Leder BZ, et al. Gonadal steroid-dependent effects on bone turnover and bone mineral density in men. J Clin Invest. 2016;126(3):1114\u201325. https:\/\/doi.org\/10.1172\/JCI84137.","journal-title":"J Clin Invest"},{"issue":"7","key":"971_CR62","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/andr.13411","volume":"11","author":"S Willems","year":"2023","unstructured":"Willems S, David K, Decallonne B, Marcq P, Antonio L, Vanderschueren D. The effect of testosterone treatment on bone mineral density in Klinefelter syndrome: A retrospective cohort study. Andrology. 2023;11(7):1295\u2013302. https:\/\/doi.org\/10.1111\/andr.13411.","journal-title":"Andrology"},{"issue":"7","key":"971_CR63","doi-asserted-by":"publisher","first-page":"526","DOI":"10.7326\/0003-4819-110-7-526","volume":"110","author":"SL Greenspan","year":"1989","unstructured":"Greenspan SL, Oppenheim DS, Klibanski A. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med. 1989;110(7):526\u201331. https:\/\/doi.org\/10.7326\/0003-4819-110-7-526.","journal-title":"Ann Intern Med"},{"issue":"4","key":"971_CR64","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jamainternmed.2016.9539","volume":"177","author":"PJ Snyder","year":"2017","unstructured":"Snyder PJ, Kopperdahl DL, Stephens-Shields AJ, et al. Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone: a controlled clinical trial. JAMA Intern Med. 2017;177(4):471\u20139. https:\/\/doi.org\/10.1001\/jamainternmed.2016.9539.","journal-title":"JAMA Intern Med"},{"key":"971_CR65","doi-asserted-by":"publisher","unstructured":"Peresuh SJ, Arcand PH, Confessore J, et al. A matched retrospective analysis: The relationship between testosterone replacement therapy and the incidence of hip fractures.\u00a0J Am Acad Orthop Surg. Published online July 3, 2025https:\/\/doi.org\/10.5435\/JAAOS-D-24-01334","DOI":"10.5435\/JAAOS-D-24-01334"},{"issue":"6","key":"971_CR66","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1210\/jc.2011-3045","volume":"97","author":"NB Watts","year":"2012","unstructured":"Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(6):1802\u201322. https:\/\/doi.org\/10.1210\/jc.2011-3045.","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"971_CR67","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, et al. Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25(10):2359\u201381. https:\/\/doi.org\/10.1007\/s00198-014-2794-2.","journal-title":"Osteoporos Int"},{"issue":"3","key":"971_CR68","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1359\/JBMR.0301240","volume":"19","author":"ER Larsen","year":"2004","unstructured":"Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res. 2004;19(3):370\u20138. https:\/\/doi.org\/10.1359\/JBMR.0301240.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"971_CR69","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2147\/tcrm.s3552","volume":"4","author":"JA Sunyecz","year":"2008","unstructured":"Sunyecz JA. The use of calcium and vitamin D in the management of osteoporosis. Ther Clin Risk Manag. 2008;4(4):827\u201336. https:\/\/doi.org\/10.2147\/tcrm.s3552.","journal-title":"Ther Clin Risk Manag"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-026-00971-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-026-00971-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-026-00971-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:48:14Z","timestamp":1778892494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-026-00971-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["971"],"URL":"https:\/\/doi.org\/10.1007\/s11914-026-00971-4","relation":{},"ISSN":["1544-2241"],"issn-type":[{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,16]]},"assertion":[{"value":"23 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}